Literature DB >> 33743717

Disease activity index is associated with subclinical atherosclerosis in childhood-onset systemic lupus erythematosus.

Priscila B S Medeiros1,2, Roberta G Salomão3, Sara R Teixeira4, Diane M Rassi5, Luciana Rodrigues1, Davi C Aragon1, Priscila G Fassini6, Fábio V Ued3, Rita C Tostes5, Jacqueline P Monteiro1,3, Virgínia P L Ferriani1,2, Luciana M de Carvalho7,8,9.   

Abstract

BACKGROUND: Systemic lupus erythematosus (SLE) is an independent risk factor for cardiovascular events. The present study determined the prevalence of subclinical atherosclerosis in childhood-onset SLE using the carotid intima-media thickness (CIMT) measurement and investigated associations between traditional and nontraditional risk factors for atherosclerosis, such as medications, SLE Disease Activity Index - SLEDAI-2 K and SLICC-ACR damage index and CIMT.
METHODS: Cross-sectional prospective study between 2017 and 2018. CIMT was assessed by ultrasonography. Data were collected by chart review, nutritional evaluation and laboratory tests and analyzed by Fisher, Wilcoxon-Mann-Whitney tests, multiple linear and log binomial regression.
RESULTS: Twenty-eight patients (mean age 13.9 years, SD 3) were enrolled. The prevalence of subclinical atherosclerosis was 32% (95% CI 14.8, 49.4). The mean CIMT was 0.43 ± 0.035 mm. The most common traditional risk factors observed were dyslipidemia (82.1%), uncontrolled hypertension (14.2%), obesity (14.3%), and poor diet (78.6%). Uncontrolled hypertension (p = 0.04), proteinuria (p = 0.02), estimated glomerular filtration rate < 75 ml /min/1.73 m2 (p = 0.02) and SLEDAI-2 K > 5 (P = 0.04) were associated with subclinical atherosclerosis. SLEDAI-2 K > 5 maintained association with CIMT after adjusting for control variables.
CONCLUSION: Subclinical atherosclerosis is frequently observed in cSLE, mainly in patients with moderate to severe disease activity.

Entities:  

Keywords:  Atherosclerosis; Carotid intima-media thickness; Lupus Erythematosus, systemic, childhood; Nutritional assessment

Year:  2021        PMID: 33743717      PMCID: PMC7981852          DOI: 10.1186/s12969-021-00513-5

Source DB:  PubMed          Journal:  Pediatr Rheumatol Online J        ISSN: 1546-0096            Impact factor:   3.054


  44 in total

Review 1.  Subclinical atherosclerosis in systemic lupus erythematosus.

Authors:  Yasmeen Ahmad; Ian N Bruce
Journal:  J Rheumatol       Date:  2004-05       Impact factor: 4.666

Review 2.  Classification criteria for systemic lupus erythematosus: a review.

Authors:  M Petri; L Magder
Journal:  Lupus       Date:  2004       Impact factor: 2.911

Review 3.  Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis.

Authors:  Matthias W Lorenz; Hugh S Markus; Michiel L Bots; Maria Rosvall; Matthias Sitzer
Journal:  Circulation       Date:  2007-01-22       Impact factor: 29.690

Review 4.  An update on childhood-onset systemic lupus erythematosus.

Authors:  Julie Barsalou; Deborah M Levy; Earl D Silverman
Journal:  Curr Opin Rheumatol       Date:  2013-09       Impact factor: 5.006

5.  Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus.

Authors:  F Falaschi; A Ravelli; A Martignoni; D Migliavacca; M Sartori; A Pistorio; G Perani; A Martini
Journal:  Arthritis Rheum       Date:  2000-06

Review 6.  Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade.

Authors:  George K Bertsias; Jane E Salmon; Dimitrios T Boumpas
Journal:  Ann Rheum Dis       Date:  2010-09       Impact factor: 19.103

7.  Systemic lupus erythematosus disease activity index 2000.

Authors:  Dafna D Gladman; Dominique Ibañez; Murray B Urowitz
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

8.  Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort.

Authors:  Laura E Schanberg; Christy Sandborg; Huiman X Barnhart; Stacy P Ardoin; Eric Yow; Gregory W Evans; Kelly L Mieszkalski; Norman T Ilowite; Anne Eberhard; Deborah M Levy; Yukiko Kimura; Emily von Scheven; Earl Silverman; Suzanne L Bowyer; Lynn Punaro; Nora G Singer; David D Sherry; Deborah McCurdy; Marissa Klein-Gitelman; Carol Wallace; Richard Silver; Linda Wagner-Weiner; Gloria C Higgins; Hermine I Brunner; Lawrence Jung; Jennifer B Soep; Ann Reed
Journal:  Arthritis Rheum       Date:  2009-05

9.  Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Kashif Jafri; Alexis Ogdie; Atif Qasim; Sarah L Patterson; Milena Gianfrancesco; Zara Izadi; Patricia Katz; Jinoos Yazdany; Gabriela Schmajuk
Journal:  Clin Rheumatol       Date:  2017-10-09       Impact factor: 2.980

10.  Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association.

Authors:  Elaine M Urbina; Richard V Williams; Bruce S Alpert; Ronnie T Collins; Stephen R Daniels; Laura Hayman; Marc Jacobson; Larry Mahoney; Michele Mietus-Snyder; Albert Rocchini; Julia Steinberger; Brian McCrindle
Journal:  Hypertension       Date:  2009-09-03       Impact factor: 10.190

View more
  1 in total

Review 1.  Endothelial function and endothelial progenitor cells in systemic lupus erythematosus.

Authors:  Anselm Mak; Jerry Kok Yen Chan
Journal:  Nat Rev Rheumatol       Date:  2022-04-07       Impact factor: 20.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.